Passiv røyking av cannabis - hva skal vi tro?

Tidsskrift for den Norske Laegeforening

Volumn 129, Issue 2, 2009, Pages 109-113

  Westin, Andreas Austgulen ^a   Slørdal, Lars ^a,b  

^a TRONDHEIM UNIVERSITY HOSPITAL   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABINOID;

BLOOD; CANNABIS SMOKING; HUMAN; INDOOR AIR POLLUTION; METABOLISM; REVIEW; SMOKE; URINE;

AIR POLLUTION, INDOOR; CANNABINOIDS; HUMANS; MARIJUANA SMOKING; SMOKE;

EID: 59249093822     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.09.33889     Document Type: Article

References (32)

1. SIRUS. Rusmidler i Norge 2006. Oslo: Statens institutt for rusmiddelforsking, 2006: 112-8.
2. Law B, Mason PA, Moffat AC et al. Passive inhalation of cannabis smoke. J Pharm Pharmacol 1984; 36: 578-81.
3. Busuttil A, Obafunwa JO, Bulgin S. Passive inhalation of cannabis smoke: a novel defence strategy? J Clin Forensic Med 1996; 3: 99-104.
4. Kvamme S. Hvordan kan jeg røyke cannabis og løpe fort? Dagbladet 14.8.2007.
5. Perez-Reyes M, Di Guiseppi S, Mason AP et al. Passive inhalation of marihuana smoke and urinary excretion of cannabinoids. Clin Pharmacol Ther 1983; 34: 36-41.
6. Mason AP, Perez-Reyes M, McBay AJ et al. Cannabinoid concentrations in plasma after passive inhalation of marijuana smoke. J Anal Toxicol 1983; 7: 172-4.
7. Perez-Reyes M, di Guiseppi S, Davis KH. Passive inhalation of marijuana smoke and urinary excretion cannabinoids. JAMA 1983; 249: 475.
8. Mason AP, Perez-Reyes M, McBay AJ et al. Cannabinoids in plasma after passive inhalation of marijuana smoke. JAMA 1983; 249: 475-6.
9. Mørland J, Bugge A, Skuterud B et al. Cannabinoids in blood and urine after passive inhalation of Cannabis smoke. J Forensic Sci 1985; 30: 997-1002.
10. Cone EJ, Johnson RE. Contact highs and urinary cannabinoid excretion after passive exposure to marijuana smoke. Clin Pharmacol Ther 1986; 40: 247-56.
11. Cone EJ, Johnson RE, Darwin WD et al. Passive inhalation of marijuana smoke: urinalysis and room air levels of delta-9-tetrahydrocannabinol. J Anal Toxicol 1987; 11: 89-96.
12. Cone EJ, Roache JD, Johnson RE. Effects of passive exposure to marijuana smoke. NIDA Res Monogr 1987; 76: 150-6.
13. Cone EJ. Marijuana effects and urinalysis after passive inhalation and oral ingestion. NIDA Res Monogr 1990; 99: 88-96.
14. Mule SJ, Lomax P, Gross SJ. Active and realistic passive marijuana exposure tested by three immunoassays and GC/MS in urine. J Anal Toxicol 1988; 12: 113-6.
15. Niedbala S, Kardos K, Salamone S et al. Passive cannabis smoke exposure and oral fluid testing. J Anal Toxicol 2004; 28: 546-52.
16. Niedbala RS, Kardos KW, Fritch DF et al. Passive cannabis smoke exposure and oral fluid testing. II. Two studies of extreme cannabis smoke exposure in a motor vehicle. J Anal Toxicol 2005; 29: 607-15.
17. Grotenhermen F. Pharmacokinetics and pharmacodynamics of cannabinoids. Clin Pharmacokinet 2003; 42: 327-60.
18. McGilveray IJ. Pharmacokinetics of cannabinoids. Pain Res Manag 2005; 10: 15-22A.
19. Moffat AC. Monitoring urine for inhaled cannabinoids. Arch Toxicol Suppl 1986; 9: 103-10.
20. Khiabani HZ, Mørland J. Cannabis og cannabinoider som legemidler. Tidsskr Nor Lægeforen 2007; 127: 579-82.
21. Huestis MA, Cone EJ. Urinary excretion half-life of 11-nor-9-carboxy-delta 9-tetrahydrocannabinol in humans. Ther Drug Monit 1998; 20: 570-6.
22. Perez-Reyes M. Marijuana smoking: factors that influence the bioavailability of tetrahydrocannabinol. NIDA Res Monogr 1990; 99: 42-62.
23. Hembree WC, Nahas GG, Zeidenberg P et al. Changes in human spermatozoa associated with high dose marihuana smoking. Adv Biosci 1978; 22-23: 429-39.
24. Zeidenberg P, Bourdon R, Nahas GG. Marijuana intoxication by passive inhalation: documentation by detection of urinary metabolites. Am J Psychiatry 1977; 134: 76-7.
25. Falck R. Passive inhalation of marijuana smoke. JAMA 1983; 250: 898.
26. Hayden JW. Passive inhalation of marijuana smoke: a critical review. J Subst Abuse 1991; 3: 85-90.
27. Cone EJ, Huestis MA. Interpretation of oral fluid tests for drugs of abuse. Ann N Y Acad Sci 2007; 1098: 51-103.
28. Kauert GF, Ramaekers JG, Schneider E et al. Pharmacokinetic properties of delta 9-tetrahydrocannabinol in serum and oral fluid. J Anal Toxicol 2007; 31: 288-93.
29. Huestis MA, Cone EJ. Relationship of delta 9-tetrahydrocannabinol concentrations in oral fluid and plasma after controlled administration of smoked cannabis. J Anal Toxicol 2004; 28: 394-9.
30. Niedbala RS, Kardos KW, Fritch DF et al. Detection of marijuana use by oral fluid and urine analysis following single-dose administration of smoked and oral marijuana. J Anal Toxicol 2001; 25: 289-303.
31. Musshoff F, Madea B. Review of biologic matrices (urine, blood, hair) as indicators of recent or ongoing cannabis use. Ther Drug Monit 2006; 28: 155-63.
32. Tsanaclis L, Wicks JF. Differentiation between drug use and environmental contamination when testing for drugs in hair. Forensic Sci Int 2008; 176: 19-22.